Biallelic ZNF142-null mutations in patients with early-onset generalized dystonia
Objective: To identify a novel genetic factor contributing to the phenotypic expression of early-onset generalized dystonia. Background: To date, only about 20-30% of cases with…Natural History of Movement Abnormalities on Hereditary Spastic Paraplegia: validation of timed functional instruments
Objective: To evaluate the natural history of Hereditary Spastic Paraplegia (HSPs) and to define sensitivity to change, minimal clinically important difference (MCID) and validity of…The Impact of the New Classification Criteria on the Incidence of Tremor Syndromes
Objective: To compare the incidence of the different tremor syndromes using 1998 versus 2018 consensus criteria for classifying tremor disorders. Background: In 1998, the Consensus…Prevalence and Patterns of Rest and Action Tremor in Drug-naïve Parkinson’s Disease
Objective: We aimed to describe the prevalence and patterns of rest and action tremor in a large, prospective cohort of Parkinson’s disease (PD) patients. Background:…GluRδ2 protein reduction in cerebellar Purkinje cells contributes to the pathogenesis of essential tremor
Objective: To identify a molecular substrate reflecting kinetic tremor, the core feature of essential tremor (ET) Background: ET is one of the most common movement…Dystonic versus parkinsonian tremor
Objective: To present cases of patients with diagnostic uncertainty between tremor in Parkinson’s disease (PD) and dystonic tremor. Background: Some patients with clinical presentation of…Memantine induced dyskinesia in Alzheimer’s disease
Objective: There is only little evidence for memantine induced dyskinesia in Alzheimer’s disease. We present a patient with Alzheimer’s disease who developed choreatic dyskinesia as a result…Chlorogenic acid and Trianthema portulacastrum combinational therapy mitigates rotenone induced Parkinsonism in wistar rats
Objective: The present study was aimed to explore the synergistic neuroprotective effect of combination of natural phenolic compound, i. e., chlorogenic acid, and butanol extract…The effect of istradefylline on mood disorders in Parkinson’s disease
Objective: The effectiveness of istradefylline for treatment of mood disorders in patients with Parkinson's disease (PD) was examined in an open-label trial. Background: Depression is…Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)
Objective: To compare the performance of the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and its predecessor, the Non-Motor Symptoms Scale (NMSS). Background: The…
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 217
- Next Page »